What's in Azienda Ospedaliera San Giovanni Battista's pipeline?

Azienda Ospedaliera San Giovanni Battista has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Azienda Ospedaliera San Giovanni Battista's portfolio?

Top competitors by shared drug class: Assistance Publique - Hôpitaux de Paris, Basque Health Service, Biogen, Eli Lilly and Company, Harbin Medical University.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/azienda-ospedaliera-san-giovanni-battista.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Azienda Ospedaliera San Giovanni Battista — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Azienda Ospedaliera San Giovanni Battista pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Fludarabin	Fludarabin	marketed		Carbonic anhydrase 5A, mitochondrial, DNA polymerase alpha catalytic subunit, Ribonucleoside-diphosphate reductase large subunit	Oncology
lysine acetylsalicylate	lysine acetylsalicylate	marketed	Nonsteroidal anti-inflammatory drug (NSAID); antiplatelet agent	Cyclooxygenase-1 (COX-1); Cyclooxygenase-2 (COX-2)	Cardiovascular; Pain management; Inflammation

Therapeutic area mix

Cardiovascular; Pain management; Inflammation · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Basque Health Service · 1 shared drug class
Biogen · 1 shared drug class
Eli Lilly and Company · 1 shared drug class
Harbin Medical University · 1 shared drug class
Janssen Scientific Affairs, LLC · 1 shared drug class
PLx Pharma · 1 shared drug class
Royal College of Surgeons, Ireland · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Azienda Ospedaliera San Giovanni Battista:

Cite this brief

Drug Landscape (2026). Azienda Ospedaliera San Giovanni Battista — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/azienda-ospedaliera-san-giovanni-battista. Accessed 2026-05-16.